Analystreport

LogicBio Therapeutics Inc (NASDAQ: LOGC) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.

ContextLogic Inc. - Class A  (LOGC) 
Last contextlogic inc. - class a earnings: 8/13 08:00 am Check Earnings Report